There are at least two things most analysts covering telecomms share in respect to AT&T Inc. (NYSE:
T)'s move to buy Time Warner Inc (NYSE:
TWX).
The first is about the challenges in getting the regulatory approval given the experience of Comcast
Corporation (NASDAQ: CMCSA)–NBC deal. However, the
New York Times' Jim Stewart gave a 98 percent chance of regulatory approval.
The second is the downgrading of Time Warner and AT&T shares, with most of them now at Neutral/Hold ratings.
Related Link: Telecomms:
The Most Interesting Sector Going Into Earnings
The following brokerages have made changes in respect of Time Warner:
- Credit Suisse downgraded from Buy to a Neutral rating but boosted target price from $90 to $107.50.
- MKM Partners downgraded from Buy to a Neutral rating.
- Goldman Sachs remove Time Warner from Conviction Buy List and downgraded to a Neutral.
- Moffett Nathanson downgraded from Buy to a Neutral rating.
- Atlantic Equities downgraded from Overweight to Neutral.
- RNC Capital Markets from Outperform to Sector Perform rating.
- Evercore ISI Group downgraded from Buy to a Neutral rating.
- Loop Capital maintains a Buy rating and lifted price objective from $96 to $107.50.
The following brokerages have made changes in respect of AT&T:
- Cowen & Co. downgraded from Outperform to Market Perform.
- Drexel Hamilton downgraded from Buy to a Hold rating.
- Wunderlich maintains Buy rating.
At Last Check ...
- AT&T was down 1.88 percent at $36.78.
- Time Warner was down 2.53 percent at $87.22.
Full ratings
data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win
a $20 Amazon gift card!
Latest Ratings for CMCSA
Date |
Firm |
Action |
From |
To |
Oct 2016 |
Macquarie |
Upgrades |
Neutral |
Outperform |
Aug 2016 |
Argus Research |
Maintains |
|
Buy |
Jul 2016 |
Pacific Crest |
Maintains |
|
Overweight |
View More Analyst Ratings for
CMCSA
View the Latest Analyst Ratings
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.